Voranigo

Active Ingredient(s): Vorasidenib
FDA Approved: * August 6, 2024
Pharm Company: * SERVIER
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Voranigo 40 mg Oral Tablet, Film Coated
NDC: 72694-728
Labeler:
Servier Pharmaceuticals LLC
Voranigo 10 mg Oral Tablet, Film Coated
NDC: 72694-879
Labeler:
Servier Pharmaceuticals LLC